IL12A and cardiac hypertrophy: Together, these findings clearly indicate that inhibition of IL-12α signaling protected heart against systolic overload-induced cardiac hypertrophy, dysfunction, and the consequent pulmonary remodeling through attenuating cardiac and lung inflammation at least partially through attenuating the activation of infiltrated antigen presenting cells and T cells.